PYLERA Drug Patent Profile
✉ Email this page to a colleague
When do Pylera patents expire, and what generic alternatives are available?
Pylera is a drug marketed by Labs Juvise and is included in one NDA.
The generic ingredient in PYLERA is bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PYLERA?
- What are the global sales for PYLERA?
- What is Average Wholesale Price for PYLERA?
Summary for PYLERA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Clinical Trials: | 7 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PYLERA |
What excipients (inactive ingredients) are in PYLERA? | PYLERA excipients list |
DailyMed Link: | PYLERA at DailyMed |
![PYLERA drug patent expirations Drug patent expirations by year for PYLERA](/p/graph/s/t/PYLERA-patent-expirations.png)
![Drug Prices for PYLERA](/p/graph/drug-price/PYLERA.png)
Paragraph IV (Patent) Challenges for PYLERA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
PYLERA | Capsules | bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride | 140 mg/125 mg/ 125 mg | 050786 | 1 | 2014-08-12 |
US Patents and Regulatory Information for PYLERA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Labs Juvise | PYLERA | bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride | CAPSULE;ORAL | 050786-001 | Sep 28, 2006 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PYLERA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Labs Juvise | PYLERA | bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride | CAPSULE;ORAL | 050786-001 | Sep 28, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Labs Juvise | PYLERA | bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride | CAPSULE;ORAL | 050786-001 | Sep 28, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Labs Juvise | PYLERA | bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride | CAPSULE;ORAL | 050786-001 | Sep 28, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PYLERA
See the table below for patents covering PYLERA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 329126 | ⤷ Sign Up | |
Argentina | 014126 | USO DE UNA SAL SOLUBLE DE BISMUTO, UN PRIMER ANTIBIOTICO Y UN SEGUNDO ANTIBIOTICO Y UNA FORMA DE DOSIFICACION FARAMACEUTICA | ⤷ Sign Up |
Turkey | 200001761 | ⤷ Sign Up | |
Indonesia | 26340 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |